5Schmits FJ, Fluit AC, Luckefahr M, et al. The effect of reserpine, an inhibitor of multidrug efflux pumps, on the invitro activities of ciprofloxacin, sparfloxacin and moxifloxacin againse clinical isolates of Staphylococcus aureus [J]. J Antimicrob Chemo
6Yamada H, Kurose-Hamada S, Fukuda Y, et al. Quinolone susceptibility of norA-disrupted[J]. Antimlcrob Agents Chemother,1997, 41(10): 2308-2314.
7Kaatz GW, Seo SM. Inducible NorA-mediated multidrug resistance in Staphylococcus aureus [J ]. Antimicrob Agents Chemother, 1995, 39(12): 2650-2657.
8Bruce RL and Skurray R. Antimicrobial resistance of Staphylococcus aureus genetic basis [J].Microbiol Revs,1987,51 (1):88-134.
9Chamber HF.Penicillin binding protein-mediated resistance in pneumococci and Staphylococci [J].J Infect Dis.,1999,171 (suppl2):353-359.
10Waldkkkkvogel FA. New resistence in staphylococcus aurus[J].N Engl J Med,1999, 340(7):556-557.
8[1]Ubukata K, Itoh NY, Konno M, et al. Cloning and expression of the norA gene for fluoroquinolone resistance in Staphylococcus aureus. [J]. Antimicrob Agents Chemother, 1989, 33(9): 1535
9[2]Yoshida H, Bogaki M, Nakamura S, et al. Nucleotide sequence and characterization of the Staphylococcus aureus norA gene, which confers resistance to quinolones. [J]. J Bacteriol,1990, 172(12): 6942
10[3]Kaatz GW, Seo SM, Ruble CA, et al. Efflux-mediated fluoroquinolone resistance in Staphylococcus aureus. [J].Antimicrob Agents Chemother, 1993, 37(5): 1086
